학술논문

Plasma Level Of miR-21 And miR-451 In Primary And Recurrent Breast Cancer Patients
Document Type
Academic Journal
Source
Breast Cancer: Targets and Therapy. October, 2019, p293, 8 p.
Subject
Iran
Canada
Language
English
ISSN
1179-1314
Abstract
Purpose: MiR-21 and miR-451 are closely associated with tumor initiation, drug resistance, and recurrence of breast cancer (BC). This study was conducted to evaluate the possible value of the plasma level of miR-21 and miR-451 as potential biomarkers for the detection of primary and recurrent BC. Patients and methods: In this descriptive-analytical study, the plasma level of miR-21 and miR-451 was measured in 23 primary BC patients, 24 recurrent (local/distant metastasis) BC patients, and 24 aged-match women as healthy controls using quantitative reverse transcription-polymerase chain reaction (qRT-PCR). Finally, data were analyzed using SPSS software, and the area under the receiver operating characteristic (ROC) curve of miRNAs was measured. Results: The plasma level of miR-21 was significantly increased in both groups of primary (P Conclusion: These data indicating that plasma miR-21 may be useful as a biomarker for the detection of both primary and recurrent BC. However, plasma miR-451 lacks enough sensitivity in the detection of primary and recurrent BC, and more studies are needed in this area. Keywords: miRNA-21, miRNA-451, breast cancer, biomarker
Introduction Breast cancer (BC) is the most common cancer and the leading cause of cancer death among females worldwide. (1) Most BC-related deaths are because of its recurrence and distant [...]